文献速递中药与中成药合理使用中医内科

五味子活性成分戈米辛A促进糖尿病皮肤创面愈合的网络药理学与体内验证

Efficacy and mechanism of Schisandra chinensis active component Gomisin A on diabetic skin wound healing: network pharmacology and in vivo experimental validation.
PubMed 文献 · J Ethnopharmacol · 2024-09-18

本研究通过网络药理学筛选五味子活性成分,发现戈米辛A与糖尿病皮肤创面靶点网络距离最近,并在高脂饮食诱导的肥胖小鼠模型中验证其可加速创面愈合,机制涉及提高胰岛素敏感性和抑制AGE-TLR4-p38 MAPK-IL6炎症通路。

要点

  • 戈米辛A是五味子促糖尿病创面愈合的关键活性成分。
  • 戈米辛A可提高胰岛素敏感性并抑制AGE-TLR4-p38 MAPK-IL6通路。
  • 网络药理学联合体内实验可预测并验证中药活性成分作用。

核心结论

  • 戈米辛A在改善糖尿病皮肤创面愈合中起关键作用。
  • 网络药理学与体内实验共同表明戈米辛A通过提高胰岛素敏感性、降低AGE介导的TLR4-p38 MAPK-IL6炎症信号通路促进创面愈合。

研究设计与样本

  • 研究采用网络药理学预测结合高脂饮食诱导的肥胖小鼠糖尿病皮肤创面模型进行体内验证。
  • 五味子成分来自TCMSP数据库并经ADME筛选,活性成分靶点来自TCMSP、SwissTargetPrediction、TargetNet和CTD数据库。
  • 糖尿病皮肤创面相关靶点来自GeneCards、OMIM、DisGeNET和PharmGKB数据库,交集网络用Gephi分析,网络邻近度预测成分与疾病模块的距离。
  • 戈米辛A以口服或局部注射方式每日给予高脂饮食诱导的肥胖小鼠直至创面愈合。

主要发现

  • 共筛选出5个五味子活性成分:戈米辛A、Longikaurin A、Deoxyharringtonine、五味子素C和Interiotherin B。
  • 这些成分可调控与糖尿病皮肤创面相关的生物过程,包括磷代谢过程正调控、细胞迁移正调控和对创伤的反应。
  • 网络邻近度分析显示戈米辛A在人类蛋白-蛋白相互作用网络中与糖尿病皮肤创面模块及药物靶点的距离-based Z-score最接近。
  • 高脂饮食诱导的肥胖小鼠模型显示戈米辛A通过提高胰岛素敏感性和降低AGE介导的TLR4-p38 MAPK-IL6炎症信号通路加速皮肤创面愈合。

临床怎么用

  • 五味子及其活性成分戈米辛A可能作为糖尿病皮肤创面愈合的潜在治疗选择。
  • 戈米辛A的作用机制涉及改善胰岛素敏感性和抑制AGE-TLR4-p38 MAPK-IL6炎症通路,可为临床干预提供靶点参考。

局限性

  • 研究仅基于网络药理学预测和高脂饮食诱导的肥胖小鼠模型,尚未在人体中验证。
  • 五味子中仅筛选出5个活性成分,其他成分的作用未纳入分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Schisandra chinensis (Turcz.) Baill., a common traditional Chinese herbal medicine, has been used for the treatment of diabetes mellitus and its complications. However, the major active component for treating diabetic foot ulcers, a serious complication of diabetes mellitus, was unclear. This study aimed to predict the treatment effect of the active components in Schisandra chinensis against diabetic skin wound using network pharmacology and to confirm the underlying mechanism using a diabetic skin wound model in vivo. AIM OF THE STUDY: To study the effects and underlying mechanisms of Schisandra chinensis and its main component Gomisin A on diabetic skin wound healing by network pharmacology and high-fat diet (HFD)-induced obese mice model in vivo. MATERIALS AND METHODS: To determine the effectiveness of Schisandra chinensis on diabetic skin wound, network pharmacology was first used. Components of Schisandra chinensis were obtained from the Traditional Chinese Medicine Systems Pharmacology database. The active components were further verified through absorption, distribution, metabolism and excretion. The potential targets of the active components were identified from the Traditional Chinese Medicine Systems Pharmacology, SwissTargetPrediction, TargetNet, and the Comparative Toxicogenomics Database. Targets related to diabetic skin wound were collected from the GeneCards, OMIM, DisGeNET, and PharmGKB databases. The interaction network formed by the intersection of the two datasets was analyzed using Gephi. Network-based proximity was used to predict the network distance between the active components of Schisandra chinensis and diabetic skin wound. Gomisin A was found to have the lowest Z-score and was administered either orally or via topical injection to HFD-induced obese mice daily until the wounds healed, and its effects on skin wound healing were evaluated. RESULTS: Only five active ingredients of Schisandra chinensis were screened in our system: Gomisin A, Longikaurin A, Deoxyharringtonine, Wuweizisu C, and Interiotherin B, which can regulate biological processes related to diabetic skin wound, including positive regulation of phosphorous metabolic process, positive regulation of cell migration, and response to wounding. Network proximity analysis found that Gomisin A has the closest distance-based Z-score among the diabetic skin wound modules and drug targets in the human protein-protein interaction network. The HFD-induced obese mice model further revealed that Gomisin A accelerated skin wound healing by increasing insulin sensitivity and decreasing the advanced glycation end-products mediated toll-like receptor 4 (TLR4)-p38 MAPK-IL6 inflammation signaling pathway. CONCLUSIONS: The network pharmacology and in vivo studies indicated that Gomisin A from Schisandra chinensis played a crucial role in improving diabetic skin wound healing.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Zhang Z, Yang W, Chen J, et al. Efficacy and mechanism of Schisandra chinensis active component Gomisin A on diabetic skin wound healing: network pharmacology and in vivo experimental validation. J Ethnopharmacol. 2024. PMID: 39303965. doi:10.1016/j.jep.2024.118828

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。